NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
07/29/2025
Back to search
Official data from USPTO
REVIVAL PHARMS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
REVIVAL PHARMS
ST13
US500000097351978Class
3, 44
Filing
97351978
Registration
7873788
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
27
Latest update
07/29/2025
Trademark type
Word
Nice classes
3, 44
Filing date
04/07/2022
Registration date
07/29/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
07/29/2025
Last transaction
07/29/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
09/26/2021
First use in commerce
11/19/2021
Drawing code
4
Owner type
16
Owner location
Lincoln, NE, US
Examiner
KEELEY, ALISON REBECCA
Law office
M40
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
R. P. (pessoa física)
Representatives
REVIVAL PHARMS
Technical classification
Nice Classes
Class 3Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 3
Natural cosmetics; none of the foregoing for medical or therapeutic use; all of the foregoing containing ingredients solely derived from hemp with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis
Class 44
Wellness and health-related consulting services
Publications
History of USPTO decisions and trademark events.
27 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
07/29/2025
TMBN
TTAB RELEASE CASE TO TRADEMARKS
07/03/2025
OP.T
OPPOSITION TERMINATED NO. 999999
07/03/2025
OP.D
OPPOSITION DISMISSED NO. 999999
07/03/2025
ETOP
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
02/26/2025
OP.I
OPPOSITION INSTITUTED NO. 999999
02/23/2025
ETOF
EXTENSION OF TIME TO OPPOSE RECEIVED
11/21/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/29/2024
PUBO
PUBLISHED FOR OPPOSITION
10/29/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/09/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/19/2024
XAEC
EXAMINER'S AMENDMENT ENTERED
09/18/2024
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
09/18/2024
GNEA
EXAMINERS AMENDMENT E-MAILED
09/18/2024
CNEA
EXAMINERS AMENDMENT -WRITTEN
09/18/2024
DOCK
ASSIGNED TO EXAMINER
10/13/2023
DOCK
ASSIGNED TO EXAMINER
06/05/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/13/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/13/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/13/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
01/26/2023
GNRT
NON-FINAL ACTION E-MAILED
01/26/2023
CNRT
NON-FINAL ACTION WRITTEN
01/26/2023
DOCK
ASSIGNED TO EXAMINER
01/25/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/12/2022
NWAP
NEW APPLICATION ENTERED
04/11/2022
Continuous trademark protection
Get notified about every new filing that threatens REVIVAL PHARMS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.